【Introduction】 The number of patients with antiresorptive agents-related osteonecrosis of the jaw (ARONJ) with osteoporosis is increasing in Japan. Tooth extraction in patients treated with antiresorptive agents (ARA) is a risk factor for ARONJ. However, there are few reports on the rate of development of ARONJ. Therefore, in this study, we aimed to clarify the rate of development rate and factors for ARONJ after tooth extraction in osteoporosis patients treated with ARA.
【Materials and Methods】 Between April 2011 to March 2019, we retrospectively enrolled 424 patients (15 men, 409 women) who were treated with ARA for osteoporosis, and underwent tooth extraction at Tokyo Dental College, Chiba Hospital and Chiba Dental Center, and examined the development and factors for ARONJ.
【Results】 The number of patients who developed ARONJ was 6 (1.4%). The results of multivariate analysis for ARONJ factors were gender (p=0.006, odds ratio=0.028, 95% confidence intervals=0.002, 0.351), risk factors (p=0.001, odds ratio=28.262, 95% confidence intervals=3.187, 250.607), and wound condition (p=0.021, odds ratio=0.068, 95% confidence intervals=0.007, 0.621).
【Conclusion】 The rate of development of ARONJ after tooth extraction in osteoporosis patients receiving ARA was 1.4%. The risk factor for ARONJ were male, risk factors in general (cancer, diabetes mellitus, rheumatoid arthritis, anemia) and combination drug (corticosteroid, anti-cancer agent), and open wound.
View full abstract